Diagnostics
HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans.
Foundation Medicine’s sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday.
Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility.
The firm said it sold the shares at an issue price of €12.50 each, and that the total 6.4 million shares represent approximately 14.3 percent of its outstanding shares.
Gritstone Oncology is hanging a “help wanted” sign as the company looks to staff a new 43,000 square-foot manufacturing facility in Pleasanton, Calif. that will be the center of the company’s immunotherapy manufacturing efforts.
Qiagen’s investment will be an expansion of its current operations in that northern England city.
Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate of acceptance of the EMA staff for relocatation, according to a survey.
The majority of the cuts will be in Germany and about 1,800 will be in the U.S.
A look at six bay area-based VCs who are creating a lot of value in biotech.
The financing was led by Zhonguancun Development Group and Shanghai Creation Investment Management.
PRESS RELEASES